Janus Henderson Group PLC Integra Lifesciences Holdings Corp Transaction History

Janus Henderson Group PLC

$207 Billion
Q3 2025

A detailed history of Janus Henderson Group PLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 33,756 shares of IART stock, worth $396,633. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,756

Previous 33,756 -0.0%

Holding current value

$396,633

Previous $414,000 16.67%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.14 - $34.72 $8,075 - $12,117	-349 Reduced 1.02%	33,756 $983,000
Q4 2023 Feb 14, 2024	SELL	$34.21 - $44.59 $2,155 - $2,809	-63 Reduced 0.18%	34,105 $1.49 Million
Q3 2023 Nov 14, 2023	SELL	$37.8 - $45.97 $302 - $367	-8 Reduced 0.02%	34,168 $1.3 Million
Q2 2023 Aug 14, 2023	SELL	$37.95 - $58.98 $63.4 Million - $98.5 Million	-1,669,911 Reduced 97.99%	34,176 $1.41 Million
Q1 2023 May 15, 2023	SELL	$52.61 - $60.49 $49.1 Million - $56.5 Million	-933,972 Reduced 35.4%	1,704,087 $97.8 Million
Q4 2022 Feb 14, 2023	SELL	$42.17 - $58.6 $22.5 Million - $31.3 Million	-534,479 Reduced 16.85%	2,638,059 $148 Million
Q3 2022 Nov 14, 2022	SELL	$42.28 - $57.17 $4.55 Million - $6.15 Million	-107,610 Reduced 3.28%	3,172,538 $134 Million
Q2 2022 Aug 15, 2022	SELL	$53.86 - $66.52 $147,791 - $182,530	-2,744 Reduced 0.08%	3,280,148 $177 Million
Q1 2022 May 16, 2022	SELL	$62.86 - $69.24 $29.3 Million - $32.2 Million	-465,392 Reduced 12.42%	3,282,892 $211 Million
Q4 2021 Feb 14, 2022	SELL	$62.47 - $73.25 $24.7 Million - $29 Million	-395,441 Reduced 9.54%	3,748,284 $251 Million
Q3 2021 Nov 16, 2021	SELL	$64.97 - $76.19 $32.4 Million - $38 Million	-499,344 Reduced 10.75%	4,143,725 $284 Million
Q2 2021 Aug 16, 2021	SELL	$66.79 - $76.63 $941,338 - $1.08 Million	-14,094 Reduced 0.3%	4,643,069 $317 Million
Q1 2021 May 17, 2021	BUY	$62.63 - $71.15 $2.19 Million - $2.49 Million	35,000 Added 0.76%	4,657,163 $322 Million
Q4 2020 Feb 16, 2021	BUY	$43.31 - $66.55 $24.8 Million - $38.1 Million	572,291 Added 14.13%	4,622,163 $300 Million
Q3 2020 Nov 16, 2020	SELL	$43.33 - $51.72 $6.3 Million - $7.52 Million	-145,314 Reduced 3.46%	4,049,872 $191 Million
Q2 2020 Aug 14, 2020	SELL	$41.42 - $55.57 $4.59 Million - $6.15 Million	-110,740 Reduced 2.57%	4,195,186 $197 Million
Q1 2020 May 14, 2020	SELL	$36.67 - $61.04 $253,793 - $422,457	-6,921 Reduced 0.16%	4,305,926 $192 Million
Q4 2019 Feb 18, 2020	BUY	$55.73 - $62.49 $60.5 Million - $67.9 Million	1,086,385 Added 33.67%	4,312,847 $251 Million
Q3 2019 Nov 14, 2019	SELL	$53.29 - $64.59 $1.19 Million - $1.45 Million	-22,408 Reduced 0.69%	3,226,462 $194 Million
Q2 2019 Jul 31, 2019	BUY	$46.45 - $55.85 $17.4 Million - $21 Million	375,546 Added 13.07%	3,248,870 $181 Million
Q1 2019 Apr 30, 2019	BUY	$42.97 - $57.33 $29.6 Million - $39.5 Million	688,761 Added 31.53%	2,873,324 $160 Million
Q4 2018 Feb 06, 2019	BUY	$42.62 - $64.51 $7.48 Million - $11.3 Million	175,432 Added 8.73%	2,184,563 $98.5 Million
Q3 2018 Nov 09, 2018	BUY	$57.63 - $65.87 $2.47 Million - $2.82 Million	42,790 Added 2.18%	2,009,131 $132 Million
Q2 2018 Aug 10, 2018	BUY	$54.05 - $67.23 $19.7 Million - $24.6 Million	365,254 Added 22.81%	1,966,341 $127 Million
Q1 2018 May 14, 2018	SELL	$46.55 - $57.38 $124,055 - $152,917	-2,665 Reduced 0.17%	1,601,087 $88.6 Million
Q4 2017 Feb 09, 2018	SELL	$46.22 - $51.77 $19.9 Million - $22.3 Million	-431,536 Reduced 21.2%	1,603,752 $76.8 Million
Q3 2017 Nov 14, 2017	SELL	$47.8 - $53.63 $985,874 - $1.11 Million	-20,625 Reduced 1.0%	2,035,288 $0
Q2 2017 Aug 17, 2017	BUY	N/A	2,055,913	2,055,913 $112 Million

Others Institutions Holding IART

# of Institutions

233

Shares Held

79.7M

Call Options Held

24.6K

Put Options Held

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $981M
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Integra Lifesciences Holdings Corp Transaction History